• Biomind will delist its common shares from Cboe Canada effective at the close of business on Aug. 10, 2026.
• The move follows a planned shift in primary trading venue tied to its upcoming listing on the Canadian Securities Exchange.
• Common shares are set to begin trading on the Canadian Securities Exchange at the market open on Aug. 11, 2026 under “BMND”.
• Shareholders do not need to take action; the company’s OTC Pink listing remains unchanged.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biomind Labs Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202608061615ACCESSWRNAPR_____1202924) on August 06, 2026, and is solely responsible for the information contained therein.